Created in 2013 (United States), Acerta Pharma own 585 sister brands and 17478 competing brands. Acerta Pharma is owned by ASTRAZENECA, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0009895292. Acerta Pharma belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(Acerta Pharma)
over 5 years*
GBX 25,721.57